Launch Date
06/16/2022 at 8:00 am
Credit Amount
0.5 Hours
Credit Expires
06/16/2023
Current treatments for alopecia areata (AA) include topical and systemic anti-inflammatories, immunosuppressants, and immunosensitizers depending on patient age and disease severity. Because these therapeutic options produce variable clinical outcomes, each case must be approached on a customized, individual basis. A developing pipeline of immunomodulating agents (e.g. Janus kinase inhibitors) offers promise to bridge significant treatment gaps left by current therapies. It is important that clinicians who treat patients with AA elevate their knowledge of both current and emerging therapies for AA in order to enhance best practices and patient outcomes.
Join us for the third installment of this three-part virtual Journal Club series, More Than Hair Loss: Current and Emerging Therapies for Alopecia Areata, as Drs. Nekma Meah and Dmitri Wall explore the evolving landscape of AA treatment.
At the end of this CME/CE activity, participants should be able to review current and emerging treatments for AA.
Supported by an educational grant from Pfizer Inc.
Physicians, PAs, and nurse practitioners specializing in dermatology, allergy/immunology, general practice, and/or pediatrics located outside of the United States
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Meah reports no financial relationships.
Dr. Wall reports the following financial relationships:
Consultant: Bristol Myers Squibb and Pfizer Inc. (on behalf of the National and International Skin Registry)
Grants/Research Support: Janssen Global Services, LLC and Pfizer Inc.
Other: National and International Skin Registry Solutions (Charity)
The following peer reviewer and CME Outfitters staff report no financial relationships:
Shirley Michelle Franks, MSN, APRN, FNP-BC (peer reviewer)
Kellie Busby, PharmD (planning committee)
Susan Perry (planning committee)
Susan H. Yarbrough, CHCP (planning committee)
Sharon Tordoff (planning committee)
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.
Call us at 877.CME.PROS (877.263.7767).
JC-024-061622-02